Is IDEAYA Biosciences, Inc. (IDYA) a Buy, Sell, or Hold?
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$36.65 USD
$0.5 (1.38%)
- Volume
- 1.21M
- Average Volume
- 1.24M
- Market Capitalization
- $3.48B
- P/E Ratio
- -23.20
- Dividend Yield
- 0.00%
- Price Target
- $58.00
- Year High
- $40.58
- Year Low
- $21.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.74
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
17
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
2
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 19100
IDYA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
IDYA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Ruiz Briseno Andres | officer: Chief Accounting Officer | 2026-07-07 | M-Exempt | 12.86 | 2026-07-09 |
| Ruiz Briseno Andres | officer: Chief Accounting Officer | 2026-07-07 | S-Sale | 40.0137 | 2026-07-09 |
| Ruiz Briseno Andres | officer: Chief Accounting Officer | 2026-07-07 | M-Exempt | 12.86 | 2026-07-09 |
| YARNO WENDY L | director | 2026-06-16 | A-Award | 30.57 | 2026-06-18 |
| Stein Jeffrey | director | 2026-06-16 | A-Award | 30.57 | 2026-06-18 |
| ROSEN TERRY J | director | 2026-06-16 | A-Award | 30.57 | 2026-06-18 |
| Morrison Scott W | director | 2026-06-16 | A-Award | 30.57 | 2026-06-18 |
| MACKEY CATHERINE J | director | 2026-06-16 | A-Award | 30.57 | 2026-06-18 |
| Hampton Malcolm Garret | director | 2026-06-16 | A-Award | 30.57 | 2026-06-18 |
| Ross Theodora | officer: Chief Development Officer | 2026-03-18 | 31.9 | 2026-06-05 | |
| Stein Jeffrey | director | 2026-03-02 | P-Purchase | 32.9578 | 2026-03-02 |
| Bleharski Joshua | officer: Chief Financial Officer | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| Beaupre Darrin | officer: Chief Medical Officer | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| DORMAN STUART | officer: Chief Commercial Officer | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| Hata Yujiro S | director, officer: President and CEO | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| Snyder Douglas B. | officer: SVP, General Counsel | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| Snyder Douglas B. | officer: SVP, General Counsel | 2025-11-28 | A-Award | 16.9065 | 2026-02-02 |
| Snyder Douglas B. | officer: SVP, General Counsel | 2025-05-30 | A-Award | 16.9065 | 2026-02-02 |
| Ruiz Briseno Andres | officer: See Remarks | 2026-01-30 | A-Award | 32.19 | 2026-02-02 |
| Ruiz Briseno Andres | officer: See Remarks | 2025-11-28 | A-Award | 16.9065 | 2026-02-02 |
| Ruiz Briseno Andres | officer: See Remarks | 2024-11-29 | A-Award | 23.256 | 2026-02-02 |
| Bleharski Joshua | officer: Chief Financial Officer | 2025-06-27 | 20.05 | 2025-06-27 | |
| YARNO WENDY L | director | 2025-06-24 | A-Award | 21.78 | 2025-06-26 |
| Stein Jeffrey | director | 2025-06-24 | A-Award | 21.78 | 2025-06-26 |
| Hampton Malcolm Garret | director | 2025-06-24 | A-Award | 21.78 | 2025-06-26 |
| Morrison Scott W | director | 2025-06-24 | A-Award | 21.78 | 2025-06-26 |
| MACKEY CATHERINE J | director | 2025-06-24 | A-Award | 21.78 | 2025-06-26 |
| ROSEN TERRY J | director | 2025-06-24 | A-Award | 21.78 | 2025-06-26 |
| Beaupre Darrin | officer: Chief Medical Officer | 2025-02-27 | A-Award | 20.24 | 2025-02-28 |
| DORMAN STUART | officer: Chief Commercial Officer | 2025-02-27 | A-Award | 20.24 | 2025-02-28 |
| Ruiz Briseno Andres | officer: See Remarks | 2025-02-27 | A-Award | 20.24 | 2025-02-28 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2025-02-27 | A-Award | 20.24 | 2025-02-28 |
| Snyder Douglas B. | officer: SVP, General Counsel | 2025-02-27 | A-Award | 20.24 | 2025-02-28 |
| Hata Yujiro S | director, officer: President and CEO | 2025-02-27 | A-Award | 20.24 | 2025-02-28 |
| Hata Yujiro S | director, officer: President and CEO | 2025-02-18 | M-Exempt | 19.52 | 2025-02-19 |
| Hata Yujiro S | director, officer: President and CEO | 2025-02-18 | M-Exempt | 19.52 | 2025-02-19 |
| DORMAN STUART | officer: Chief Commercial Officer | 2024-12-11 | 27.45 | 2024-12-20 | |
| Snyder Douglas B. | officer: SVP, General Counsel | 2024-09-26 | A-Award | 30.5 | 2024-09-27 |
| Snyder Douglas B. | 2024-09-18 | 0 | 2024-09-27 | ||
| Throne Jason | officer: Chief Legal Officer | 2024-06-27 | M-Exempt | 7.01 | 2024-06-27 |
| Throne Jason | officer: Chief Legal Officer | 2024-06-27 | M-Exempt | 13.34 | 2024-06-27 |
| Throne Jason | officer: Chief Legal Officer | 2024-06-27 | M-Exempt | 13.34 | 2024-06-27 |
| Throne Jason | officer: Chief Legal Officer | 2024-06-27 | M-Exempt | 7.01 | 2024-06-27 |
| ROSEN TERRY J | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| Kelley Susan L. | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| Hampton Malcolm Garret | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| Stein Jeffrey | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| Morrison Scott W | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| YARNO WENDY L | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| MACKEY CATHERINE J | director | 2024-05-31 | A-Award | 36.55 | 2024-05-31 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2024-05-29 | M-Exempt | 12.86 | 2024-05-31 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2024-05-29 | M-Exempt | 12.86 | 2024-05-31 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2024-05-29 | S-Sale | 36.2251 | 2024-05-31 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2024-05-29 | S-Sale | 36.7763 | 2024-05-31 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-15 | M-Exempt | 4.31 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-14 | M-Exempt | 4.31 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-16 | M-Exempt | 4.31 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-15 | S-Sale | 42.5741 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-16 | S-Sale | 41.7333 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-14 | S-Sale | 41.6011 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-15 | S-Sale | 43.4775 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-14 | S-Sale | 41.8357 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-16 | S-Sale | 42.366 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-15 | S-Sale | 44.1179 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-14 | M-Exempt | 4.31 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-15 | M-Exempt | 4.31 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-05-16 | M-Exempt | 4.31 | 2024-05-16 |
| Hata Yujiro S | director, officer: President and CEO | 2024-03-01 | A-Award | 46.22 | 2024-03-04 |
| Ruiz Briseno Andres | officer: See Remarks | 2024-03-01 | A-Award | 46.22 | 2024-03-04 |
| Beaupre Darrin | officer: Chief Medical Officer | 2024-03-01 | A-Award | 46.22 | 2024-03-04 |
| WHITE MICHAEL ANTHONY | officer: Chief Scientific Officer | 2024-03-01 | A-Award | 46.22 | 2024-03-04 |
| Throne Jason | officer: Chief Legal Officer | 2024-03-01 | A-Award | 46.22 | 2024-03-04 |
| Ruiz Briseno Andres | officer: See Remarks | 2024-02-09 | S-Sale | 46.0223 | 2024-02-13 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-08 | M-Exempt | 4.31 | 2024-02-12 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-09 | M-Exempt | 4.31 | 2024-02-12 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-09 | S-Sale | 45.537 | 2024-02-12 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-08 | S-Sale | 45.1472 | 2024-02-12 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-08 | M-Exempt | 4.31 | 2024-02-12 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-09 | M-Exempt | 4.31 | 2024-02-12 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-01 | M-Exempt | 4.31 | 2024-02-05 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-01 | S-Sale | 45 | 2024-02-05 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-01 | S-Sale | 45.01 | 2024-02-05 |
| Hata Yujiro S | director, officer: President and CEO | 2024-02-01 | M-Exempt | 4.31 | 2024-02-05 |
| Ruiz Briseno Andres | officer: See Remarks | 2024-01-22 | S-Sale | 42.0251 | 2024-01-24 |
| Ruiz Briseno Andres | officer: See Remarks | 2024-01-12 | S-Sale | 38.0128 | 2024-01-17 |
| Hata Yujiro S | director, officer: President and CEO | 2024-01-16 | M-Exempt | 4.31 | 2024-01-17 |
| Hata Yujiro S | director, officer: President and CEO | 2024-01-12 | M-Exempt | 4.31 | 2024-01-17 |
| Hata Yujiro S | director, officer: President and CEO | 2024-01-12 | S-Sale | 40.0386 | 2024-01-17 |
| Hata Yujiro S | director, officer: President and CEO | 2024-01-16 | S-Sale | 40.1659 | 2024-01-17 |
| Hata Yujiro S | director, officer: President and CEO | 2024-01-12 | M-Exempt | 4.31 | 2024-01-17 |
| Hata Yujiro S | director, officer: President and CEO | 2024-01-16 | M-Exempt | 4.31 | 2024-01-17 |
| Throne Jason | officer: Chief Legal Officer | 2023-12-18 | M-Exempt | 7.01 | 2023-12-19 |
| Throne Jason | officer: Chief Legal Officer | 2023-12-15 | M-Exempt | 13.34 | 2023-12-19 |
| Throne Jason | officer: Chief Legal Officer | 2023-12-15 | M-Exempt | 13.34 | 2023-12-19 |
| Throne Jason | officer: Chief Legal Officer | 2023-12-18 | M-Exempt | 7.01 | 2023-12-19 |
| Throne Jason | officer: Chief Legal Officer | 2023-12-15 | S-Sale | 35.0371 | 2023-12-19 |
| Hata Yujiro S | director, officer: President and CEO | 2023-12-15 | M-Exempt | 4.31 | 2023-12-19 |
| Hata Yujiro S | director, officer: President and CEO | 2023-12-15 | S-Sale | 35.0349 | 2023-12-19 |
| Hata Yujiro S | director, officer: President and CEO | 2023-12-15 | M-Exempt | 4.31 | 2023-12-19 |